Assessment of the Contribution of Insulin-like Growth Factor I Receptor 3174 G→A Polymorphism to the Progression of Advanced Retinopathy of Prematurity

Abstract

Purpose

Retinopathy of prematurity (ROP) is a leading cause of blindness in children with short gestational age and low birthweight. The condition can cause abnormal vessel development that can lead to retinal detachment and blindness. It has been recently reported that a low level of insulin-like growth factor I (IGF-I) is associated with ROP. However, the most prevalent polymorphism of IGF-I receptor (IGF-IR 3174 G→A) that was reported to be producing low level of IGF-I was not found to be associated with ROP in a certain population. In order to reproduce this data in a different cohort and to learn more about the contribution of IGF-IR polymorphism to ROP, the authors hypothesized that it is possible that such a polymorphism would occur more frequently in a different cohort of infants with advanced ROP than those children with mild or no disease.

Methods

For genetic analysis, eligible patients were selected consecutively by experienced pediatric ophthalmologists and leukocyte DNA from affected (n=52) and normal patients (n=33) were amplified by polymerase chain reaction. The amplified products were subjected to restriction enzyme digestion with 10 units of MnlI enzyme. The digested products were analyzed by polyacrylamide gel electrophoresis followed by ethidium bromide staining to visualize the restriction fragment length polymorphism.

Results

The analysis suggests that there is no statistically significant difference in allelic frequency of the most prevalent IGF-IR gene polymorphism between normal subjects and patients with ROP in this cohort. The G→A polymorphism did not occur more frequently in patients with ROP.

Conclusions

The results do not support the association of the most prevalent IGF-IR gene polymorphism and the risk of advanced ROP in a different cohort, confirming the earlier report.

Keywords

Growth factor Polymorphism Prematurity Receptor Retinopathy

Get full access to this article

View all access options for this article.

References

Reynolds

J.D.

, Hardy

R.J.

, Kennedy

K.A.

, Spencer

, van Heuven

W.A.J.

, Fielder

R.R.

Lack of efficacy of light reduction in preventing retinopathy of prematurity. N Engl J Med 1998; 338: 1572–6.

Shastry

B.S.

, Pendergast

, Hartzer

M.K.

, Liu

, Trese

M.T.

Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol 1997; 115: 651–6.

Haider

M.Z.

, Devarajan

L.V.

, Al-Essa

, Kumar

A C597A polymorphism in the Norrie disease gene is associated with advanced retinopathy of prematurity in premature Kuwaiti infants. J Biomed 2002; 9: 365–70.

Hutcheson

K.A.

, Paluru

P.C.

, Bernstein

S.L.

Norrie disease gene sequence variants in ethnically diverse population with retinopathy of prematurity. Mol Vis 2005; 11: 501–8.

Bizzarro

M.J.

, Hussain

, Jonsson

Genetic susceptibility to retinopathy of prematurity. Pediatrics 2006; 118: 1858–63.

Hellstrom

, Engstrom

, Hard

A-L

Postnatal serum insulin-like growth factor–I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003; 112: 1016–20.

Balogh

, Derzbach

, Vannay

, Vasarhelyi

Lack of association between insulin-like growth factor I receptor G+3174A polymorphism and retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1035–8.